Manifestaciones cutáneas de la dermatomiositis
Resumen
La dermatomiositis es una enfermedad que hace parte de las miopatías inflamatorias, cuyo hallazgo distintivo es la afectación cutánea. En la mayoría de los casos el compromiso cutáneo precede a la afección muscular; por lo tanto, es de vital importancia para el dermatólogo el reconocimiento de la manifestaciones cutáneas en dermatomiositis, con el fin de hacer un diagnóstico oportuno de la enfermedad y emprender un tratamiento efectivo para evitar complicaciones futuras.
Biografía del autor/a
Juan Pablo Restrepo
Médico internista, reumatólogo; profesor, Universidad del Quindío, Armenia, Colombia.
Luis Fernando Medina
Médico internista, reumatólogo; profesor, Universidad del Valle, Cali, Colombia
María del Pilar Molina
Médica y cirujana, Universidad Libre, Cali, Colombia.
Referencias bibliográficas
1. Bohan A, Peter F. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344-7.
2. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22:668-74.
3. Targoff I, Miller F, Medsger T, Oddis C. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997;9:527-35.
4. Kovacs S, Kovacs C. Dermatomyositis. J Am Acad Dermatol. 1998;39:899-920.
5. Symmons D, Sills J, Davis S. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol. 1995;34:732-6.
6. Oddis C, Conte C, Steen V, Medsger T. Incidence of polymyositis-dermatomyositis: a 20-year study of hispital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol. 1990; 7:1329-34.
7. Targoff I. Dermatomyositis and polymyositis. Curr Probl Dermatol. 1991;3:131-80.
8. Dalakas M. Polymyositis, dermatomyositis and inclusionbody myositis. N Engl J Med. 1991;325:1487-98.
9. Greenberg S. Inflammatory myophaties: evaluation and management. Semin Neurol. 2008;28:241-9.
10. Dalakas M, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-82.
11. Rockerbie N, Woo T, Callen J, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol. 1989;20:629-32.
12. Barkhaus P, Nandedkar S, Sanders D. Quantitative EMG in inflammatory myopathy. Muscle Nerve. 1990;13:247-53.
13. Wiendl H. Idiopathic inflammatory myopathies: current and future therapeutic options. Neurotherapeutics. 2008;5:548-57.
14. Schumacher H, Schirmmer B, Gordon G, Bookspan M, Brogadir S, Dorwart B. Articular manifestations of polymyositis and dermatomyositis. Am J Med. 1979;67:287-92.
15. De Merierux P, Verity M, Clements P, Paulus H. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum. 1983;26:961-8.
16. Marie I, Hatron P, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 1998;25:1336-43.
17. Selva-O’Callaghan A, Labrador-Horillo M, Munoz-Gall X, Martínez-Gomez X, Majó-Masferrer J, Solans-Laque R, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus. 2005;14:534-42.
18. Fathi M, Dastmalchi M, Rasmussen E, Lundberg I, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004;63:297-301.
19. González-López L, Gámez-Nava J, Sánchez L, Rosas E, Suárez-Almazor M, Cardona-Muñoz C, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 1996;14:373-9.
20. Bohan A, Peter J, Bowman R, Pearson C. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977;56:255-86.
21. Taieb A, Guichard C, Salamon R, Maleville J. Prognosis in juvenile dermatomyositis : a cooperative restrospective study of 70 cases. Pediatr Dermatol. 1985;2:275-81.
22. Euwer R, Sontheimer R. Dermatologic aspects of myositis. Curr Opin Rheumatol. 1664;6:583-9.
23. Callen J. Dermatomyositis. Dermatol Clin. 1983;1:463-73.
24. Woo T, Rasmussen J, Callen J. Recurrent photosensitive dermatitis preceding juvenile dermatomyositis. Pediatr Dermatol. 1985;3:207-12.
25. Bielsa I. Dermatomiositis. Reumatol Clin. 2009;5:216-22.
26. Santmyire-Rosenberger B, Dugan E. Skin involvement in dermatomyositis. Curr Opin Rheumatol. 2003;15:714-22.
27. Stahl N, Klippel J, Decker J. A cutaneous lesion associated with myositis. Ann Intern Med. 1979;91:577-9.
28. Mitra D, Lovell C, Macleod T, Tan R, Maddison P. Clinical and histological features of “mechanics hands” in a patient with antibodies to Jo-1: a case report. Clin Exp Dermatol. 1994;19:146-8.
29. Baron M, Small P. Polymyositis/dermatomyositis: clinical features and out-come in 22 patients. J Rheumatol. 1985;12:283-6.
30. Glover M, Leigh I. Dermatomyositis pemphigoides: a case with coexistent dermatomyositis and bullous pemphigoid. J Am Acad Dermatol. 1992;27:849-52.
31. Requena L, Grilli R, Soriano L, Escalonilla P, Farina C, Martin L. Dermatomyositis with a pityriasis rubra pilaris–like eruption: a little known distinctive cutaneous manifestation of dermatomyositis. Br J Dermatol. 1997;136:768-71.
32. Feldman D, Hochberg M, Zizic T, Stevens M. Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol. 1983;10:85-9.
33. Raimer S, Solomon A, Daniels J. Polymyositis presenting with panniculitis. J Am Acad Dermatol. 1985;13:366-9.
34. Neidenbach P, Sahn E, Helton J. Panniculitis in juvenile dermatomyositis. J Am Acad Dermatol. 1995;33:305-7.
35. Winkelman WJ, Billick RC, Srolovitz H. Dermatomyositis presenting as panniculitis. J Am Acad Dermatol. 1990;23:127-8.
36. Launay D, Hatron PY, Delaporte E, Hachulla E, Devulder B, Piette F. Scleromyxedema (lichen myxedematosus) associated with dermatomyositis. Br J Dermatol. 2001;144:359 -62.
37. Nousari H, Ha V, Laman S, Provost T, Tausk F. Centripetal flagellate erythema T: a cutaneous manifestation associated with dermatomyositis. J Rheumatol. 1999;26:692-5.
38. Urrutia S, Vázquez F, Requena L, Sánchez, Yus E. Acquired ichthyosis associated with dermatomyositis. J Am Acad Dermatol. 1987;16:627-9.
39. Pierson J, Taylor J. Erythrodermic dermatomyositis. J Am Acad Dermatol. 1993;28:136.
40. Miyagawa S, Okazaki A, Minowa R, Shirai T. Dermatomyositis presenting as erythroderma. J Am Acad Dermatol. 1992;26:489-90.
41. Al-Najjar A, Reilly G, Harrington C. Dermatomyositis and lichen planus: an association or manifestation? Clin Exp Dermatol. 1985;10:174-8.
42. Martínez-Cordero E, Katona G. Nasal septal perforation in dermatomyositis. J Rheumatol. 1986;13:231-2.
43. Caro I. Dermatomyositis. Semin Cutaneous Med Surg. 2001;20:38-41.
44. Koler R, Montemarano A. Dermatomyositis. Am Fam Physician. 2001;64.1565-72.
45. Cox N, Lawrence C, Langtry J, Ive FA. Dermatomyositis. Arch Dermatol. 1990;126:61-5.
46. Callen J, Wortmann R. Dermatomyositis. Clin Dermatol. 2006;24:363-73.
47. Pautas E, Cherin P, Piette J, Pelletier S, Wechsler B, Cabane J, et al. Features of polymyositis and dermatomyositis in the elderly: a case-control study. Clin Exp Rheumatol. 2000;18:241-4.
48. Chakravarty E, Genovese M. Rheumatic syndromes associated with malignancy. Curr Opin Rheumatol. 2003;15:35-43.
49. Hill C, Zhang Y, Sigurgeirsson B, Pukkale E, Mellemkjaer V, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet. 2001;357:96-100.
50. Callen J. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol. 2002;138:969-71.
51. Caro I. A dermatologist’s view of polymyositis/dermatomyositis. Clin Dermatol. 1988;6:9-14.
52. Hollar C, Jorizzo J. Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatolog Treat. 2004;15:35-9.
53. Stonecipher M, Callen J, Jorizzo J. The red face: Dermatomyositis. Clin Dermatol. 1993;11:261-73.
54. Woo T, Callen J, Voorhees J, Bickers D, Hanno R, Hawkins C. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol. 1984;10:592-600.
55. Zieglschmid-Adams M, Pandya A, Cohen S, Sontheimer R. Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol. 1995;32:754-7.
56. Kasteler J, Callen J. Low-dose methotrexate administered weekly in an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol. 1997;36:667-71.
57. Edge J, Outland J, Dempsey J, Callen J. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol. 2006;142:65-9.
2. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22:668-74.
3. Targoff I, Miller F, Medsger T, Oddis C. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997;9:527-35.
4. Kovacs S, Kovacs C. Dermatomyositis. J Am Acad Dermatol. 1998;39:899-920.
5. Symmons D, Sills J, Davis S. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol. 1995;34:732-6.
6. Oddis C, Conte C, Steen V, Medsger T. Incidence of polymyositis-dermatomyositis: a 20-year study of hispital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol. 1990; 7:1329-34.
7. Targoff I. Dermatomyositis and polymyositis. Curr Probl Dermatol. 1991;3:131-80.
8. Dalakas M. Polymyositis, dermatomyositis and inclusionbody myositis. N Engl J Med. 1991;325:1487-98.
9. Greenberg S. Inflammatory myophaties: evaluation and management. Semin Neurol. 2008;28:241-9.
10. Dalakas M, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-82.
11. Rockerbie N, Woo T, Callen J, Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol. 1989;20:629-32.
12. Barkhaus P, Nandedkar S, Sanders D. Quantitative EMG in inflammatory myopathy. Muscle Nerve. 1990;13:247-53.
13. Wiendl H. Idiopathic inflammatory myopathies: current and future therapeutic options. Neurotherapeutics. 2008;5:548-57.
14. Schumacher H, Schirmmer B, Gordon G, Bookspan M, Brogadir S, Dorwart B. Articular manifestations of polymyositis and dermatomyositis. Am J Med. 1979;67:287-92.
15. De Merierux P, Verity M, Clements P, Paulus H. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum. 1983;26:961-8.
16. Marie I, Hatron P, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 1998;25:1336-43.
17. Selva-O’Callaghan A, Labrador-Horillo M, Munoz-Gall X, Martínez-Gomez X, Majó-Masferrer J, Solans-Laque R, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus. 2005;14:534-42.
18. Fathi M, Dastmalchi M, Rasmussen E, Lundberg I, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004;63:297-301.
19. González-López L, Gámez-Nava J, Sánchez L, Rosas E, Suárez-Almazor M, Cardona-Muñoz C, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 1996;14:373-9.
20. Bohan A, Peter J, Bowman R, Pearson C. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977;56:255-86.
21. Taieb A, Guichard C, Salamon R, Maleville J. Prognosis in juvenile dermatomyositis : a cooperative restrospective study of 70 cases. Pediatr Dermatol. 1985;2:275-81.
22. Euwer R, Sontheimer R. Dermatologic aspects of myositis. Curr Opin Rheumatol. 1664;6:583-9.
23. Callen J. Dermatomyositis. Dermatol Clin. 1983;1:463-73.
24. Woo T, Rasmussen J, Callen J. Recurrent photosensitive dermatitis preceding juvenile dermatomyositis. Pediatr Dermatol. 1985;3:207-12.
25. Bielsa I. Dermatomiositis. Reumatol Clin. 2009;5:216-22.
26. Santmyire-Rosenberger B, Dugan E. Skin involvement in dermatomyositis. Curr Opin Rheumatol. 2003;15:714-22.
27. Stahl N, Klippel J, Decker J. A cutaneous lesion associated with myositis. Ann Intern Med. 1979;91:577-9.
28. Mitra D, Lovell C, Macleod T, Tan R, Maddison P. Clinical and histological features of “mechanics hands” in a patient with antibodies to Jo-1: a case report. Clin Exp Dermatol. 1994;19:146-8.
29. Baron M, Small P. Polymyositis/dermatomyositis: clinical features and out-come in 22 patients. J Rheumatol. 1985;12:283-6.
30. Glover M, Leigh I. Dermatomyositis pemphigoides: a case with coexistent dermatomyositis and bullous pemphigoid. J Am Acad Dermatol. 1992;27:849-52.
31. Requena L, Grilli R, Soriano L, Escalonilla P, Farina C, Martin L. Dermatomyositis with a pityriasis rubra pilaris–like eruption: a little known distinctive cutaneous manifestation of dermatomyositis. Br J Dermatol. 1997;136:768-71.
32. Feldman D, Hochberg M, Zizic T, Stevens M. Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol. 1983;10:85-9.
33. Raimer S, Solomon A, Daniels J. Polymyositis presenting with panniculitis. J Am Acad Dermatol. 1985;13:366-9.
34. Neidenbach P, Sahn E, Helton J. Panniculitis in juvenile dermatomyositis. J Am Acad Dermatol. 1995;33:305-7.
35. Winkelman WJ, Billick RC, Srolovitz H. Dermatomyositis presenting as panniculitis. J Am Acad Dermatol. 1990;23:127-8.
36. Launay D, Hatron PY, Delaporte E, Hachulla E, Devulder B, Piette F. Scleromyxedema (lichen myxedematosus) associated with dermatomyositis. Br J Dermatol. 2001;144:359 -62.
37. Nousari H, Ha V, Laman S, Provost T, Tausk F. Centripetal flagellate erythema T: a cutaneous manifestation associated with dermatomyositis. J Rheumatol. 1999;26:692-5.
38. Urrutia S, Vázquez F, Requena L, Sánchez, Yus E. Acquired ichthyosis associated with dermatomyositis. J Am Acad Dermatol. 1987;16:627-9.
39. Pierson J, Taylor J. Erythrodermic dermatomyositis. J Am Acad Dermatol. 1993;28:136.
40. Miyagawa S, Okazaki A, Minowa R, Shirai T. Dermatomyositis presenting as erythroderma. J Am Acad Dermatol. 1992;26:489-90.
41. Al-Najjar A, Reilly G, Harrington C. Dermatomyositis and lichen planus: an association or manifestation? Clin Exp Dermatol. 1985;10:174-8.
42. Martínez-Cordero E, Katona G. Nasal septal perforation in dermatomyositis. J Rheumatol. 1986;13:231-2.
43. Caro I. Dermatomyositis. Semin Cutaneous Med Surg. 2001;20:38-41.
44. Koler R, Montemarano A. Dermatomyositis. Am Fam Physician. 2001;64.1565-72.
45. Cox N, Lawrence C, Langtry J, Ive FA. Dermatomyositis. Arch Dermatol. 1990;126:61-5.
46. Callen J, Wortmann R. Dermatomyositis. Clin Dermatol. 2006;24:363-73.
47. Pautas E, Cherin P, Piette J, Pelletier S, Wechsler B, Cabane J, et al. Features of polymyositis and dermatomyositis in the elderly: a case-control study. Clin Exp Rheumatol. 2000;18:241-4.
48. Chakravarty E, Genovese M. Rheumatic syndromes associated with malignancy. Curr Opin Rheumatol. 2003;15:35-43.
49. Hill C, Zhang Y, Sigurgeirsson B, Pukkale E, Mellemkjaer V, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet. 2001;357:96-100.
50. Callen J. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol. 2002;138:969-71.
51. Caro I. A dermatologist’s view of polymyositis/dermatomyositis. Clin Dermatol. 1988;6:9-14.
52. Hollar C, Jorizzo J. Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatolog Treat. 2004;15:35-9.
53. Stonecipher M, Callen J, Jorizzo J. The red face: Dermatomyositis. Clin Dermatol. 1993;11:261-73.
54. Woo T, Callen J, Voorhees J, Bickers D, Hanno R, Hawkins C. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol. 1984;10:592-600.
55. Zieglschmid-Adams M, Pandya A, Cohen S, Sontheimer R. Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol. 1995;32:754-7.
56. Kasteler J, Callen J. Low-dose methotrexate administered weekly in an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol. 1997;36:667-71.
57. Edge J, Outland J, Dempsey J, Callen J. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol. 2006;142:65-9.
Cómo citar
1.
Restrepo JP, Medina LF, Molina M del P. Manifestaciones cutáneas de la dermatomiositis. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 14 de febrero de 2019 [citado 14 de mayo de 2024];18(1):18-24. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/186
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2019-02-14
Cómo citar
1.
Restrepo JP, Medina LF, Molina M del P. Manifestaciones cutáneas de la dermatomiositis. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 14 de febrero de 2019 [citado 14 de mayo de 2024];18(1):18-24. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/186
Número
Sección
Artículo de revisión
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
